Silibinin improves palmitate-induced insulin resistance in C2C12 myotubes by attenuating IRS-1/PI3K/Akt pathway inhibition
The present study investigated the effect of silibinin, the principal potential anti-inflammatory flavonoid contained in silymarin, a mixture of flavonolignans extracted from Silybum marianum seeds, on palmitate-induced insulin resistance in C2C12 myotubes and its potential molecular mechanisms. Sil...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Associação Brasileira de Divulgação Científica
2015-05-01
|
Series: | Brazilian Journal of Medical and Biological Research |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2015000500440&lng=en&tlng=en |
id |
doaj-b1dad858226b4854a1e7e08c8fd8f9bb |
---|---|
record_format |
Article |
spelling |
doaj-b1dad858226b4854a1e7e08c8fd8f9bb2020-11-24T23:04:57ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research1414-431X2015-05-0148544044610.1590/1414-431X20144238S0100-879X2015000500440Silibinin improves palmitate-induced insulin resistance in C2C12 myotubes by attenuating IRS-1/PI3K/Akt pathway inhibitionH.B. LiY.R.Y. YangZ.J. MoY. DingW.J. JiangThe present study investigated the effect of silibinin, the principal potential anti-inflammatory flavonoid contained in silymarin, a mixture of flavonolignans extracted from Silybum marianum seeds, on palmitate-induced insulin resistance in C2C12 myotubes and its potential molecular mechanisms. Silibinin prevented the decrease of insulin-stimulated 2-NBDG (2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxy-D-glucose) uptake and the downregulation of glutamate transporter type 4 (GLUT4) translocation in C2C12 myotubes induced by palmitate. Meanwhile, silibinin suppressed the palmitate-induced decrease of insulin-stimulated Akt Ser473 phosphorylation, which was reversed by wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase (PI3K). We also found that palmitate downregulated insulin-stimulated Tyr632 phosphorylation of insulin receptor substrate 1 (IRS-1) and up-regulated IRS-1 Ser307 phosphorylation. These effects were rebalanced by silibinin. Considering several serine/threonine kinases reported to phosphorylate IRS-1 at Ser307, treatment with silibinin downregulated the phosphorylation of both c-Jun N-terminal kinase (JNK) and nuclear factor-κB kinase β (IKKβ), which was increased by palmitate in C2C12 myotubes mediating inflammatory status, whereas the phosphorylation of PKC-θ was not significantly modulated by silibinin. Collectively, the results indicated that silibinin prevented inhibition of the IRS-1/PI3K/Akt pathway, thus ameliorating palmitate-induced insulin resistance in C2C12 myotubes.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2015000500440&lng=en&tlng=enSilibininInsulin resistancePalmitateC2C12 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
H.B. Li Y.R.Y. Yang Z.J. Mo Y. Ding W.J. Jiang |
spellingShingle |
H.B. Li Y.R.Y. Yang Z.J. Mo Y. Ding W.J. Jiang Silibinin improves palmitate-induced insulin resistance in C2C12 myotubes by attenuating IRS-1/PI3K/Akt pathway inhibition Brazilian Journal of Medical and Biological Research Silibinin Insulin resistance Palmitate C2C12 |
author_facet |
H.B. Li Y.R.Y. Yang Z.J. Mo Y. Ding W.J. Jiang |
author_sort |
H.B. Li |
title |
Silibinin improves palmitate-induced insulin resistance in C2C12 myotubes by attenuating IRS-1/PI3K/Akt pathway inhibition |
title_short |
Silibinin improves palmitate-induced insulin resistance in C2C12 myotubes by attenuating IRS-1/PI3K/Akt pathway inhibition |
title_full |
Silibinin improves palmitate-induced insulin resistance in C2C12 myotubes by attenuating IRS-1/PI3K/Akt pathway inhibition |
title_fullStr |
Silibinin improves palmitate-induced insulin resistance in C2C12 myotubes by attenuating IRS-1/PI3K/Akt pathway inhibition |
title_full_unstemmed |
Silibinin improves palmitate-induced insulin resistance in C2C12 myotubes by attenuating IRS-1/PI3K/Akt pathway inhibition |
title_sort |
silibinin improves palmitate-induced insulin resistance in c2c12 myotubes by attenuating irs-1/pi3k/akt pathway inhibition |
publisher |
Associação Brasileira de Divulgação Científica |
series |
Brazilian Journal of Medical and Biological Research |
issn |
1414-431X |
publishDate |
2015-05-01 |
description |
The present study investigated the effect of silibinin, the principal potential anti-inflammatory flavonoid contained in silymarin, a mixture of flavonolignans extracted from Silybum marianum seeds, on palmitate-induced insulin resistance in C2C12 myotubes and its potential molecular mechanisms. Silibinin prevented the decrease of insulin-stimulated 2-NBDG (2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxy-D-glucose) uptake and the downregulation of glutamate transporter type 4 (GLUT4) translocation in C2C12 myotubes induced by palmitate. Meanwhile, silibinin suppressed the palmitate-induced decrease of insulin-stimulated Akt Ser473 phosphorylation, which was reversed by wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase (PI3K). We also found that palmitate downregulated insulin-stimulated Tyr632 phosphorylation of insulin receptor substrate 1 (IRS-1) and up-regulated IRS-1 Ser307 phosphorylation. These effects were rebalanced by silibinin. Considering several serine/threonine kinases reported to phosphorylate IRS-1 at Ser307, treatment with silibinin downregulated the phosphorylation of both c-Jun N-terminal kinase (JNK) and nuclear factor-κB kinase β (IKKβ), which was increased by palmitate in C2C12 myotubes mediating inflammatory status, whereas the phosphorylation of PKC-θ was not significantly modulated by silibinin. Collectively, the results indicated that silibinin prevented inhibition of the IRS-1/PI3K/Akt pathway, thus ameliorating palmitate-induced insulin resistance in C2C12 myotubes. |
topic |
Silibinin Insulin resistance Palmitate C2C12 |
url |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2015000500440&lng=en&tlng=en |
work_keys_str_mv |
AT hbli silibininimprovespalmitateinducedinsulinresistanceinc2c12myotubesbyattenuatingirs1pi3kaktpathwayinhibition AT yryyang silibininimprovespalmitateinducedinsulinresistanceinc2c12myotubesbyattenuatingirs1pi3kaktpathwayinhibition AT zjmo silibininimprovespalmitateinducedinsulinresistanceinc2c12myotubesbyattenuatingirs1pi3kaktpathwayinhibition AT yding silibininimprovespalmitateinducedinsulinresistanceinc2c12myotubesbyattenuatingirs1pi3kaktpathwayinhibition AT wjjiang silibininimprovespalmitateinducedinsulinresistanceinc2c12myotubesbyattenuatingirs1pi3kaktpathwayinhibition |
_version_ |
1725628293712969728 |